FDA Approved Products
4,491 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
APHTHASOL
amlexanox
LOE Approaching
DENTAL · PASTE
1996
NDA30/100
APOKYN
apomorphine hydrochloride
LOE Approaching
SUBCUTANEOUS · INJECTABLE
Parkinson's disease
2004
NDA30/100
APRESOLINE
hydralazine hydrochloride
LOE Approaching
Novartis
ORAL · TABLET
hypertension
1953
NDA30/100
APTIVUS
tipranavir
LOE Approaching
Boehringer Ingelheim
ORAL · CAPSULE
hepatitis B
2005
SMNDA30/100
APTIVUS
tipranavir
LOE Approaching
Boehringer Ingelheim
ORAL · SOLUTION
hepatitis B
2008
SMNDA30/100
APTIVUS
tipranavir
LOE Approaching
Boehringer Ingelheim
ORAL · SOLUTION
hepatitis B
2008
SMNDA30/100
AQUAMEPHYTON
phytonadione
LOE Approaching
R-Pharm US
INJECTION · INJECTABLE
the following coagulation disorders which are due to faulty formation of factors IIinterference with vitamin K activity: • anticoagulant-induced hypoprothrombinemia caused by coumarin+2
1960
NDA30/100
AQUASOL A
water-miscible retinyl palmitate
LOE Approaching
R-Pharm US
INJECTION · INJECTABLE
1949
NDA30/100
AQUATAG
benzthiazide
LOE Approaching
ORAL · TABLET
1965
NDA30/100
AQUATENSEN
methyclothiazide
LOE Approaching
Bausch Health
ORAL · TABLET
1977
NDA30/100
ARALEN
chloroquine phosphate
LOE Approaching
Sanofi
ORAL · TABLET
1949
NDA30/100
ARALEN HYDROCHLORIDE
chloroquine hydrochloride
LOE Approaching
Sanofi
INJECTION · INJECTABLE
1949
NDA30/100
ARALEN PHOSPHATE W/ PRIMAQUINE PHOSPHATE
chloroquine phosphate; primaquine phosphate
LOE Approaching
Sanofi
ORAL · TABLET
1968
NDA30/100
ARAMINE
metaraminol bitartrate
LOE Approaching
Merck & Co.
INJECTION · INJECTABLE
1954
NDA30/100
ARAVA
leflunomide
LOE Approaching
Sanofi
ORAL · TABLET
rheumatoid arthritis
1998
NDA30/100
ARDUAN
pipecuronium bromide
LOE Approaching
Merck & Co.
INJECTION · INJECTABLE
1990
NDA30/100
AREDIA
pamidronate disodium
LOE Approaching
Novartis
INJECTION · INJECTABLE
moderatesevere hypercalcemia associated with malignancy+6
1998
NDA30/100
AREDIA
pamidronate disodium
LOE Approaching
Novartis
INJECTION · INJECTABLE
moderatesevere hypercalcemia associated with malignancy+6
1991
NDA30/100
ARESTIN
minocycline hydrochloride
LOE Approaching
DENTAL · POWDER, EXTENDED RELEASE
2001
NDA30/100
ARFONAD
trimethaphan camsylate
LOE Approaching
Roche
INJECTION · INJECTABLE
1954
NDA30/100
ARGATROBAN
argatroban
LOE Approaching
Novartis
INJECTION · INJECTABLE
For prophylaxis or treatment of thrombosis
2000
NDA30/100
ARGATROBAN IN DEXTROSE
argatroban
LOE Approaching
Novartis
INTRAVENOUS · SOLUTION
For prophylaxis or treatment of thrombosis
2011
NDA30/100
ARGATROBAN IN SODIUM CHLORIDE
argatroban
LOE Approaching
INTRAVENOUS · INJECTABLE
For prophylaxis or treatment of thrombosis
2011
NDA30/100
ARICEPT
donepezil hydrochloride
LOE Approaching
Eisai
ORAL · SOLUTION
dementia of the Alzheimer's typeAlzheimer's disease
2004
NDA30/100